Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

COVID-19

Articles on the impact, diagnosis and treatment of the novel coronavirus and COVID-19

Sorrento Reports Positive Topline Results from China Trial of COVID Therapy 

WestVac Biopharma Approved to Launch COVID-19 Vaccine for XBB Variants

Clover Launches COVID-19 Vaccine in China as Second Booster Dose

Junshi Bio’s NDA for COVID-19 Therapy Accepted for Review in China

WestGene Biopharma Completes $21 Million Funding for mRNA Drugs

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here